Trial Profile
Bioavailability Study Comparing Two Solid Oral Formulations of GLPG0634 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Sep 2013
Price :
$35
*
At a glance
- Drugs Filgotinib (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2013 New trial record